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Abstract: In tissue engineering, it is still rare today to see clinically transferable strategies for 
tissue-engineered graft production that conclusively offer better tissue regeneration than the 
already existing technologies, decreased recovery times, and less risk of complications. Here a 
novel tissue-engineering concept is presented for the production of living bone implants com-
bining 1) a nanofibrous and microporous implant as cell colonization matrix and 2) 3D bone 
cell spheroids. This combination, double 3D implants, shows clinical relevant thicknesses for 
the treatment of an early stage of bone lesions before the need of bone substitutes. The strategy 
presented here shows a complete closure of a defect in nude mice calvaria after only 31 days. 
As a novel strategy for bone regenerative nanomedicine, it holds great promises to enhance the 
therapeutic efficacy of living bone implants.
Keywords: bioengineering, implants, osteoblasts, matrix mineralization, microtissues
Introduction
In the last two decades there has been considerable development in tissue repair, 
through tissue-engineering techniques and sophisticated biomaterials. These develop-
ments do not only aim at producing substitutes for damaged organs but also participate 
in the development of regenerative medicine in order to restore tissue function. In 
particular, there has been increasing interest in developing smart scaffolds mimicking 
the extracellular matrix, in order to favor long-term cell grafting.1 Structural design of 
biomimetic scaffolds has been improved at the micro- and nanoscale using designed 
nanostructures, from nanofibers,2,3 to nanogrooves,4,5 and using different nanomaterials 
such as carbon nanotubes6,7 and graphene material.8,9 Nanotechnologies like nanopar-
ticles or nanoreservoirs have also been introduced for the bioactivation of the scaffolds 
through the controlled release of bioactive therapeutics.10–15
During the consolidation of a fracture, or during the continuous physiological bone 
remodeling, bone regeneration takes place. Medical applications for tissue-engineered 
(TE) bone implants can be divided into four categories. 1) Bone fracture: 10% of the 
bone fractures (1.5 million patients per annum worldwide) cannot be treated by stan-
dard therapies (autogenous, allogeneic, and xenogeneic grafts) because the damaged 
sites are too large.16 2) Spinal fusion: some bone tissue from the patient himself or 
from a donor, is combined with the natural bone formation to fuse the vertebrae. This 
procedure, by causing immobilization of the vertebrae, enables elimination of the pain 
caused by their abnormal motion.17,18 3) Sinus lift: in dentistry the loss of upper back 
teeth results over time in some bone shrinkage or resorption in the corresponding area, 
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as a consequence, the sinuses will expand in the empty space 
left by the bone loss. A sinus lift is required to place a dental 
implant to provide the needed space for introducing additional 
bone in that area.19,20 4) Alveolar ridge augmentations: these 
consist of surgical bone grafting procedures for patients 
suffering from bone loss in the upper jaw. The number of 
patients in this field amounts to approximately 4.5 million 
per annum worldwide.21–25 Among these clinical applications, 
some require the use of filling the defect by the means of 
bone substitutes to mimic mechanical properties of bone. The 
regenerative medicine domain aims to regenerate bone in the 
case of early lesions with biomaterials close to physiologi-
cal environment of bone. These biomaterials will be used to 
prevent and to avoid the necessity of bone substitutes. In this 
case bone mechanical properties are not required.
In bone tissue engineering, natural biomaterials (such as 
collagen and cellulose) or synthetic ones (such as metals and 
ceramics) have been evaluated for their applicability to improve 
the bone healing process.24 First-generation implants mostly 
comprised metal materials (eg, dental titanium implants) 
and were created to restore the function of the injured tissue. 
Unfortunately, over time they often led to inflammation and 
infection, were subject to joint loosening process, and failed 
to achieve proper cell adhesion. Later, a second generation of 
implant biomaterials emerged, on the basis of the use of well-
tolerated nontoxic medical grade-labeled materials containing a 
bioactive component to induce a specific cell response, such as 
hip prostheses coated with the osteoconductive hydroxyapatite. 
However, such implants are not completely integrated within 
living tissues, as they do not induce efficient cell adhesion 
and are still subjected to detachment.26 The third generation, 
now under investigation, focuses on hybrid and nanostruc-
tured materials. Those bioactive materials incorporate inert 
nanostructured scaffolds and living cells to engineer living 
biomaterials capable of guiding bone healing.25
The bone regenerative nanomedicine market is a new niche 
applying biomimetic scaffolds, growth factors, and/or cells to 
restore living tissues in the case of small early lesions as preven-
tive nanomedicine. In this manuscript we will describe the use 
of nanofibrous and microporous scaffolds and human primary 
bone cells. For the achievement of damaged tissue reconstruction 
and functional recovery, cell-based tissue-engineering therapies 
require the presence of 3D scaffolds to boost the regenerative 
potential of autologous primary cells or stem cells. These 
3D scaffolds require perfectly defined tunable structural and 
mechanical properties to achieve this purpose. A large number 
of scientific researches have been focused on the development 
of 3D scaffolds for specific tissue applications, using fabrica-
tion techniques such as electrospinning, microfabrication, 
lithography, or self-assembly.27 Next-generation implants target 
robust, durable, and rapid tissue regeneration. The double 3D 
advanced implants reported here are 3D “nest-egg-like”, thick 
nanofiber-based implants seeded with 3D living human micro-
tissues (MTs) rather than single cells. It has been established 
that the efficiency of 3D living cells in tissue engineering is 
related to their capacity to mimic the embryonic development, 
and reproduce physiological properties.28,29
The actual needs of the regenerative medicine field are not 
only to increase the speed of bone regeneration but also to use 
non-animal-origin compounds. Collagen membranes clini-
cally used today are unfortunately of animal origin. We report 
here a new approach in bone tissue regeneration resulting in 
a superior bone mineralization in a nude mice calvaria defect 
model, combining 3D nanofibrous poly(ε-caprolactone) (PCL) 
material (US Food and Drug Administration-approved syn-
thetic polymer for clinical use)15,30 together with preformed 
well-organized 3D bone MTs derived from human primary 
osteoblasts (OBs). This sophisticated double 3D strategy could 
enhance the efficacy of therapeutic implants without adding 
bioactive molecules. By combining this 3D nanofibrous 
implant with preformed tridimensional bone MTs derived 
from OBs, we have recently reported in a short communica-
tion31 that it is possible to achieve a more efficient bone regen-
eration than when using just single cells. In this work we have 
characterized in detail the new bone formation with additional 
characterization techniques, to validate the concept.
Materials and methods
electrospinning
The poly (ε-caprolactone) nanofibrous scaffolds were 
fabricated with a standard electrospinning apparatus (EC-
DIG; IME Technologies, Geldrop, the Netherlands). PCL, 
analytical grade (Perstorp AB, Perstorp, Sweden) was dis-
solved in dichloromethane/dimethylformamide (40/60, v/v), 
27% (w/v) and stirred overnight before use. The PCL solution 
(5 mL syringe) dispensed at a flow rate of 1.2 mL/h (ProSense 
pump) was ejected through a 21 G needle (0.8 mm outer 
diameter), undergoing an electric potential difference. The 
fiber collector was placed at 16 cm height from the needle, a 
voltage of +15 kV was applied on the needle, and -5 kV was 
applied on the collector during the electrospinning process. 
The electrospun fiber jet was projected into a localized hole 
(diameter of 25 mm) drilled in a poly(methyl methacrylate) 
mask (2.5 mm thick) placed over the conductive collector.30
scanning electron microscopy
The electrospun PCL scaffold was gold-coated (Edwards 
Sputter Coater) and examined under a scanning electron 
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microscope (SEM; Hitachi TM1000) operating in conven-
tional mode (high vacuum).
cell culture
OBs from PromoCell GmbH (Heidelberg, Germany) were 
grown in a specific OB growth medium (PromoCell) contain-
ing supplement mix (PromoCell) and incubated at 37°C in a 
humid atmosphere with 5% CO
2
. Cells, when reaching sub-
confluence, were harvested with trypsin and subcultured.
Microtissue culture
For the formation of microtissues (MTs), OB cells were 
seeded in GravityPLUS™ plates (InSphero AG, Zürich, 
Switzerland) at a density of 2.5×105 cells/mL. Each MT was 
formed from 1×104 cells and was grown for 5 days. For in 
vitro studies and in vivo implantations OB-MTs were then 
collected and seeded onto the PCL scaffolds.
cell viability and proliferation
A total of 4×104 OB single cells were seeded on top of PCL 
scaffolds deposited in 48-well plates (n=3) and four OB-MTs 
of 1×104 cells each were seeded onto other PCL scaffolds 
for comparison (n=3). After 3 days of culture, the plates 
were incubated in 10% AlamarBlue®/Dulbecco’s Modified 
Eagle’s Medium (Thermo Fisher Scientific, Waltham, MA, 
USA) solution, in a humid atmosphere at 37°C and 5% CO
2
. 
After 4 hours, 200 µL of incubation medium from each well 
was transferred to 96-well plates and measured at 570 and 
630 nm to calculate the percentage of AlamarBlue reduction. 
The same protocol was applied again at 14 and 21 days to 
study cell proliferation.
In vitro mineralization analysis
After 28 days of culture, these samples were incubated for 
20 minutes in Alizarin Red staining solution (2%, w/v) and 
rinsed several times with distilled water. The samples were 
then embedded in Tissue-Tek® optimum cutting temperature 
(OCT) Compound and cut in 35 µm thin sections using a 
cryostat (Leica Jung CM3000), for observation under optical 
microscope (Leica DM4000 B).
confocal microscopy
OBs or OB-MTs were seeded onto PCL electrospun scaffolds 
and grown for 1, 3, or 21 days. After fixation of the samples 
with paraformaldehyde 4%, cell nuclei were stained using 
200 nM 4′,6-diamidino-2-phenylindole(DAPI) solution 
(Sigma-Aldrich Chimie S.a.r.l., Lyon, France) and scaf-
fold nanofibers were stained by soaking the scaffold in a 
fluorescent poly-lysine-fluorescein isothiocyanate solution. 
Samples were examined with a confocal microscope Zeiss 
LSM 700.
Fluorescence microscopy
After their 5 days of growth in GravityPLUS™ plates 
(InSphero), OB-MTs were fixed with 4% paraformaldehyde 
solution, permeabilized with 0.1% Triton X-100, and incu-
bated in Alexa Fluor 546-conjugated phalloidin (Molecular 
Probes, Fisher Scientific, Illkirch-Graffenstaden, France) for 
F-actin staining and in 200 nM DAPI solution (Sigma-Aldrich 
Co.) for cell nuclei staining. Samples were observed under a 
fluorescence microscope (Leica DM4000 B).
calvaria defects and in vivo implantation
Mice experiments were performed in accordance with 
the current European Union regulations (Directive 
2010/63/EU), authorized and controlled by investigator 
Dr N Benkirane-Jessel (Director of the Osteoarticular and 
Dental Regenerative Nanomedicine team), holder of an appro-
priate license for this study from “Préfecture du Bas-Rhin” 
(number 67-315). All experiments were done in an approved 
laboratory (the “Animalerie Centrale de la Faculté de Médecine 
de Strasbourg”) with the approval number A 67-482-35 from 
the Veterinary Public Health Service of the “Préfecture du 
Bas-Rhin,” on behalf of the French Ministry of Agriculture, 
Department of Veterinary Science. For tissue implantations, all 
surgery was performed under ketamine and xylazine anesthe-
sia following established protocols, and all efforts were made 
to avoid or minimize animal suffering. Anesthesia was real-
ized by intraperitoneal injection of ketamine 100 mg/kg (Vir-
bac Santé Animale; Centravet, Nancy, France) and xylazine 
10 mg/kg (Rompun,® [Bayer Healthcare, Division Animal 
Health, France] 2%). After anesthesia, 6-week-old nude 
mice (Crl: NIH-Foxn1nu; Charles River, L’Arbresle, France) 
underwent a surgical double implantation in the calvaria: on 
one side of the calvaria a PCL 3D implant (500 µm thick, 
2 mm of diameter) seeded with hOB single cells, and on the 
other side a PCL 3D implant seeded with OB-MTs. The calva-
ria defects (500 µm deep and 2 mm in diameter) were drilled 
in the parietal zone of the skull using a sterile round burr, 
under irrigation of sterile saline solution, before implantation 
of the scaffolds. For the whole study, approximately 35 mice 
were used. After 4 weeks of implantation, mice were sacri-
ficed by intraperitoneal injection of a deadly dose of ketamine 
and the implants were extracted for further analysis.
In vivo calcein injection
Injections of calcein in phosphate-buffered saline (10 mg/kg, 
Sigma-Aldrich Co.) were performed subcutaneously on mice, 
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
5.
21
0.
59
.2
16
 o
n 
22
-M
ar
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
450
Keller et al
on the third and tenth days before necropsy. Four weeks after 
the calvaria implantation, mice were sacrificed and implants 
extracted. The samples were embedded in Tissue-Tek OCT 
Compound, frozen at -20°C and cut in sections using a cry-
ostat Leica Jung CM3000. To stain cell nuclei, thin sections 
were dipped in 200 nM DAPI solution (Sigma-Aldrich) 
5 minutes. Sections were mounted using antifading medium 
and examined under fluorescence microscope.
seM-eDs X-ray
The morphology and composition of the various scaffolds 
were analyzed using a field emission SEM (Inspect™ F50; 
FEI, Hillsboro, OR USA) combined with an energy-dispersive 
X-ray spectrometer (EDS), to map the elemental composition 
of the samples. The sample surfaces were Pt-sputtered for 
allowing SEM observation and examined using an accelerating 
voltage of 10 kV and work distance of 10 mm. Statistical analy-
ses were performed using analysis of variance test (n=4).
Micro-computed tomography (cT) 
analysis of calvaria defects in nude mice
Mice were scanned with a X-ray microto mography32,33 under 
light ketamine xylazine anesthesia. Five X-ray examinations 
were performed (day [D3], D10, D17, D25, and D31 after 
surgery). For each examination, the animal was centrally 
positioned in the view field and 768 radiographies were 
acquired over 360° at 40 kV and 200 mA. Images were 
reconstructed by means of a cone-beam reconstruction 
algorithm, producing real-time 3D imagery of the linear 
attenuation coefficient with a 0.05 mm isotropic voxel size. 
The threshold used to identify bone structures was set at 
0.05 mm-1. The volume of the new bone was evaluated as 
the number of voxels above the threshold inside a region of 
interest centered on the hole. Bone growth was given as the 
percentage of bone volume visualized compared to the first 
measurement performed at D3.
Results
3D porous polymeric material for bone 
regeneration
Recently, we reported an excellent bone regeneration after 
in vivo implantation in mice using electrospun PCL nano-
fibrous implants (50 µm thick), leading to a complete cell 
colonization and bone induction inside the implant.15,34 This 
3D PCL scaffold15,30 was produced by the electrospinning 
technique (Figure 1A). The electrospun nanofiber scaffolds 
present superposition of thin nanofibrous layers (Figure 1B). 
This 3D structure leads to high-macroporosity heterogeneously 
distributed between the stratified nanofibrous layers.30 The 
nanofibers (Figure 1C) composing the superposed layers 
(Figure 1B) have a very high specific surface area per volume 
ratio, because of the small diameters of the fibers, resem-
bling the collagen extracellular matrix35 (Figure 1C and D). 
Random interactions between the different deposited nano-
fiber layers throughout the electrospinning process result in 
a random distribution of the pore sizes. These exceptional 
characteristics of nanofibrous implants are required proper-
ties for the targeted application15 as they mimic the micro- to 
nanoscale topography of the extracellular matrix, offering high 
surface area and porosity, thereby favoring cell adhesion, cell 
in-growth, and vascularization after in vivo implantation.36,37 
However, to accelerate the bone healing process, a scaffold 
alone was not sufficient. For bone repair at the early stages, 
before it becomes necessary to fill the defect with a bone sub-
stitute, regenerative nanomedicine can repair and regenerate 
bone tissue by using not only scaffolds (synthetic or collagen 
membranes), but also growth factors and cells.
Double 3D implant to increase bone 
regeneration
For small lesions intended to be treated by regenerative 
medicine, and not requiring mechanical replacement of 
bone tissue, the use of a thick rather than thin PCL electro-
spun nanofibrous scaffold is not easy to develop for bone 
regeneration. Indeed, for such lesions a thick scaffold alone 
or seeded with single cells was not sufficient to achieve 
colonization deep within the implant. The objective of this 
study was to accelerate bone mineralization in vitro and in 
vivo. We used the hOB cells, which will mineralize and 
express specific markers after seeding on the 3D scaffold. 
For regenerative medicine, the important point is to have 
expression of differentiation markers allowing induction of 
bone formation and mineralization: the faster these mark-
ers are secreted, the faster bone is regenerated. Thus here, 
time of expression prevails on quantity to compare single 
cells and MTs. This study attempted to increase the speed of 
bone growth by using OB-MTs (Figure 2) instead of single 
cells (OBs) as commonly used today.30 The formation of TE 
bone in vitro can be subdivided into two stages: (i) cellular 
colonization of the scaffold, and (ii) tissue maturation (bone 
formation) throughout the scaffold. Therefore, we evaluated 
the cell infiltration capability of single-cell OBs seeded 
onto the nanofiber scaffold (Figure 3B), and we compared 
it with OB-MT-seeded constructs after 21 days in culture 
(Figure 3E). Cell morphology, cell penetration depth, and 
bone formation were studied. Results did not reveal major 
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differences on the surface of the scaffold between OB-MT 
and OB groups (Figure 3A, B, D and E). However, staining 
for calcified tissue by Alizarin Red revealed bone formation 
in the core of the scaffolds seeded with OB-MTs at 21 days, 
in vitro (Figure 3F), whereas cell infiltration into the porous 
structure of the OB-seeded scaffold was rather limited, with 
a penetration depth in the scaffold of only a few layers, 
and not present through the entire scaffold (Figure 3C). 
Actually, this observation may explain why there has been 
in the past successful treatment of small lesions but only 
limited success in fully repopulating thicker scaffolds.15,38 
When seeding with OB-MTs instead of OB single cells, 
??????????????????????????? ????????????????
????????????????????????????
?
??????????????
?????????????????
??????????????
?????????????????
?????
??????????????????????????????????
??????????????
Figure 1 Design of 3D electrospun nanofiber scaffold.
Notes: (A) Light micrographs of different views of PCL electrospun 3D scaffold showing a superposition of thin layers made of nanofibers and interconnected macroporosity. 
(B) SEM observation of the porosity and the thin superposed layers of electropsun PCL constituting the 3D PCL (magnification of inset in A). (C) seM observation of Pcl 
nanofibers constituting thin layers of scaffold A, showing the nanoscale diameter of fibers (magnification of inset in B). (D) Parameters of the biodegradable 3D Pcl membrane: 
Fiber diameter, pore length and height, and porosity. Porosity was estimated by weight and volume of the sample. scale bars =1 mm (A); 500 µm (B); 2 µm (C).
Abbreviations: Pcl, poly(ε-caprolactone); seM, scanning electron microscope. 
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Figure 2 Osteoblastic microtissues formation and biocompatibility with nanofibrous PCL 3D.
Notes: (A) Left: fluorescence micrograph of OB-MTs stained in blue with DAPI (showing DNA) and in red with phalloidin (showing actin), just after their formation, before 
their seeding on 3D PCL. Right: confocal fluorescence microscopy visualization of OB-MTs one day after seeding onto the 3D PCL, and stained in blue with DAPI (showing 
nuclei) and in green with poly-lysine-FITC (on the nanofibers) leading to visualization of the living microtissue nesting in the implant. (B) human osteoblasts proliferation 
seeded onto the 3D electrospun implant. In vitro proliferation of human osteoblasts after seeding with single cells (OBs) or microtissues (OB-MTs) on the thick nanofiber 
implant after 3, 14, and 21 days. error bars (n=3). **P=0.01 and ***P=0.001 (analysis of variance). scale bars =100 µm.
Abbreviations: DaPI, 4′,6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; OB-MTs, human primary osteoblast microtissues; PCL, poly(ε-caprolactone); Pll, 
poly-lysine.
???
????
??
???
????
???
??
???????????? ????????????
???????? ??
??
????????????????
? ? ?
???
Figure 3 Behavior of osteoblasts seeded on 3D nanofibrous PCL as single cells or as microtissues.
Notes: Fluorescence confocal microscopy visualization (A, B, D, E) of OBs (A, B) and OB-MTs (D, E) grown onto the 3D Pcl, and visualized in blue with DaPI (DNa 
staining) and green with poly-lysine-FITC (nanofibers staining) after 3 days (A and D) and 21 days (B and E) in vitro. (C, F) ar of bone induction and mineralization on the 
3D thick PCL electrospun nanofiber seeded with OB single cells (C) and OB-MTs (F) after 21 days. scale bars =100 µm (A, B, D, E), and 1 mm (C, F).
Abbreviations: DaPI, 4′,6-diamidino-2-phenylindole; AR, Alizarin Red staining; FITC, fluorescein isothiocyanate; OB, human primary osteoblast; OB-MTs, human primary 
osteoblast microtissues; Pcl, poly(ε-caprolactone); Pll, poly-lysine.
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????????? ????????????
??
??
?????????????????? ????
? ?
Figure 4 advantage of using osteoblastic microtissues for bone mineralization and repair (double 3D strategy).
Notes: Implantation of advanced double 3D electrospun nanofiber implants in mice induces bone mineralization. In vivo bone mineralization in Pcl 3D seeded with single 
OBs (A), compared Pcl 3D seeded with OB-MTs (B), 4 weeks after calvaria implantations in nude mice. cell nuclei are labeled in blue, stained with DaPI; bone formation 
is visualized in green, tainted with calcein. scale bars =100 µm (A, B).
Abbreviations: NB, new bone; OB, human primary osteoblast; OB-MTs, human primary osteoblast microtissues; Pcl, poly(ε-caprolactone).
infiltration and bone formation within the core regions of 
the scaffold were high, as shown by Alizarin Red stain, and 
interestingly, this was not a result of accelerated cell prolif-
eration, as higher AlamarBlue reduction was observed for 
the OB-seeded scaffolds throughout the 21-day cell-culture 
time (more than double at day 21, Figure 2B). After MTs had 
adhered to the scaffold, cells even began to colonize it after 
3 days of culture, showing OB migration along nanofibers 
(Figure 3A, B, D and E).
With a view to achieve robust bone formation using a 
thick nanofibrous bone-like implant, we evaluated a novel 
tissue-engineering concept combining living OB 3D MTs 
with PCL electrospun nanofiber scaffolds by implanting 
these grafts in nude mice after creating a calvaria defect. For 
bone regeneration studies, cranial reconstruction constitutes a 
very interesting technique, because calvaria is an anatomical 
bone part undergoing limited mechanical stress, unlike axial 
skeleton, which withstands compressive loads.39,40 A hole of 
2 mm in diameter and 500 µm thick was drilled (bone defect) 
into the domelike superior portion of the mouse cranium. 
Thus, we investigated the potential improvement of bone 
formation through incorporation of living OB-MTs into the 
electrospun thick nanofibrous implant (double 3D strategy). 
We have followed in vivo bone mineralization onto PCL 3D 
scaffolds with single OBs (Figure 4A) compared to bone 
mineralization onto PCL 3D scaffolds with OB-MTs double 
3D implants (Figure 4B) 4 weeks after calvaria implanta-
tions in nude mice and calcein injection. Our results clearly 
indicate that more bone mineralization is present when using 
OB-MTs-seeded scaffolds (Figure 4B).
After confirming superior colonization and mineraliza-
tion capacity of MT-seeded scaffolds in vitro and in vivo, 
OB-MTs only (n=6) and OB-MTs seeded on a PCL scaf-
fold (n=14) were prepared as grafts for a mouse calvaria 
defect model (Figure 5). For the analysis of bone formation, 
SEM-EDS X-ray analysis was used to study the kinetics 
of calcification, in which phosphorous is shown in green, 
calcium is shown in red, and carbon is shown in blue 
(Figure 5A). Several random particles from different parts 
of the sample were selected to perform the SEM-EDS X-ray 
analysis to obtain a representative average of each sample. 
The SEM-EDS X-ray maps of the implants displayed a 
clear colocalization of calcium and phosphorous signals 
indicating new bone formation (Figure 5A). At 4 weeks 
postimplantation, Ca/P weight ratios were calculated to 
determine the conversion rate into natural bone. The control 
bone defect (hole) showed a Ca/P ratio of 0.768, whereas the 
OB-MTs without scaffold displayed a Ca/P ratio of 1.101. 
However, the PCL scaffolds loaded with living OB-MTs 
resulted in a Ca/P ratio of 1.701, indicating hydroxyapatite 
deposition, in agreement with previous literature.41 Statisti-
cal analysis showed a highly significant difference between 
OB-MT groups and PCL+OB-MTs (P0.001). We also 
used micro-CT as a noninvasive low-radiation method to 
assess the bone-defect-healing process in three dimen-
sions (Figure 5B). It produces high-resolution images and 
permits accurate quantitative analysis of bone structural 
parameters. The 3D representation of the bone defect at 
days 3, 10, 17, 25, and 31 showed that at day 3 the diameter 
of the hole was identical between each group (Figure 5B). 
In the advanced double 3D implant group, the diameter of 
the defect decreased significantly faster than in the OB-MT 
group. Quantification of bone growth over 31 days clearly 
shows an accelerated and more complete bone formation 
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when using the double 3D implant as compared with OB-MT 
implants without scaffold (Figure 5B).
Discussion
Current principles of bone tissue engineering focus on the 
material properties themselves, active molecules, and cells, 
to accelerate bone repair efficiency. Many groups develop 
3D synthetic polymeric biocompatible and biodegradable 
materials allowing osteoinduction.42–44 This 3D environ-
ment is favorable to proliferation, cell differentiation, and 
mineralization, when equipped with a large amount of single 
cells. The classical tissue-engineering strategy using single 
dispersed cells on a biocompatible biomaterial has been 
predominant over the last 20 years. However, more recently, 
it has been shown that mineralization could be accelerated 
by using cells in a 3D conformation (pellet, spheroid, MT).45 
Our strategy combines both the 3D scaffold and the 3D MTs 
instead of single cells. These 3D scaffolds are expected to 
enable cell migration and maturation through their entire thick-
ness as tissue replacement elements. However, this concept 
has shown its limitations as clinical use of TE grafts is still 
modest, because of the fact that these grafts do not allow for 
sufficient and robust bone regeneration and millions of cells are 
needed to colonize the scaffolds.46 Furthermore, the speed of 
bone regeneration needs to be improved to beneficially impact 
quality of life of the patients. In light of the huge potential of 
creating living TE grafts, new concepts have to evolve, which 
would give a clear benefit to the patient. Here we demonstrate 
that by combining two different tissue-engineering strategies, 
PCL nanofibrous scaffolds together with bone MTs, we reach 
superior bone tissue formation in vitro as well as in vivo, fol-
lowing implantation in a bony defect model without making 
use of additional growth factors (Figures 4 and 5).
Figure 5 OB-MTs seeded onto the 3D electrospun thick implant (double 3D strategy) and bone regeneration analysis.
Notes: (A) seM micrographs and seM-eDs X-ray maps showing the elemental composition as well as morphology of the grafts 4 weeks after implantation in mice calvaria. 
OB-MTs loaded with 3D Pcl or alone. elemental mapping of phosphorous (green), calcium (red), and carbon (blue) is depicted. Visualization of the grafts by seM (gray). 
(B) Micro-computed tomography (micro-cT) analysis. 3D representation of the drilled hole at day 3, leading to bone regeneration analysis of two groups of mice. group1: 
hole seeded with OB-MTs. group 2: hole after implantation of the 3D Pcl implant seeded with OB-MTs (double 3D implant). at day 3, the diameter of the holes is identical 
for each group. In the 3D Pcl + OB-MTs group, the diameter of the hole decreased faster than in the OB-MTs group. scale bars =400 µm (A).
Abbreviations: eDs, energy-dispersive X-ray spectrometer; OB-MTs, human primary osteoblast microtissues; Pcl, poly(ε-caprolactone); seM, scanning electron 
microscope. 
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Two strategies are currently used to improve tissue-
engineering efficiency: the first is making use of cells, and the 
second is based on growth factors. For instance, nowadays in 
surgery, the Medtronic collagen membrane is used and actually 
simply soaked in highly concentrated BMP-2 (bone morphoge-
netic protein-2) growth factor solution, to increase bone repair, 
but this leads to an uncontrolled release and with an excessive 
dose. In a previous publication, we had ourselves demonstrated 
that the necessity of a scaffold to improve bone induction as 
mixed capsules releasing BMP-2 together with embryonic 
stem cells, without the presence of a scaffold, could not induce 
bone regeneration, whereas by the additional implantation of 
a scaffold, bone formation was actually induced.13
It has been reported that in terms of survival, growth, 
and differentiation signals, the OB cells will secrete specific 
biomarkers such as BMPs, RANKL, IL-6, and M-CSF.47–50 
Furthermore, in vivo, biomaterials of third generation (living 
biomaterials) enable recruitment of cells to help tissue 
regeneration through paracrine secretion factors. Active 
biomaterials for bone tissue engineering are based on the 
use of active molecules or cells to improve their efficiency. 
In this work, we used OB cells as MTs, instead of single 
cells, to avoid the use of active molecules. Indeed, by using 
double 3D environment including well-organized MTs and 
3D scaffold, we demonstrated that this combination was suffi-
cient to accelerate mineralization in vitro. The combination of 
cells and scaffolds providing appropriate biological moieties 
was the most promising strategy to improve in vivo bone 
formation. In this work, the effect of MTs on the increase of 
bone mineralization speed in the double 3D implant could 
be explained by the 3D configuration, increasing the speed 
of extracellular matrix and growth factors secretion, specific 
to bone repair. Additionally, with this strategy, we observed 
an accelerated mineralization, which was not correlated with 
cell proliferation. It is consistent with the fact that cell prolif-
eration is not necessarily the major driver for cell infiltration 
and tissue maturation, and cell infiltration also depends on 
cell migration51,52 (Figure 3). Furthermore, maturation and 
mineralization occur after proliferation phase when cells exit 
from proliferative cycle. MTs allow proliferation arrest, by 
cell contact inhibition, to enter directly into maturation phase, 
leading to an accelerated mineralization. Mineralization of 
OB cells requires not only cell–cell but also cell–matrix 
interactions.53,54 By our double 3D strategy, we amplify these 
two requirements, leading to an accelerated mineralization 
and more robust bone formation in vitro as well as in vivo. 
Moreover, single cells or even MTs injection in the absence 
of a scaffold has the major disadvantage to fail in keeping 
the transplanted cells inside the defect.
The main point for a tissue-engineering solution to be clini-
cally transferable is the fast and successful maturation of new 
tissue throughout the scaffold to achieve the healing processes, 
as shown for the bone, or to replace dysfunctional tissue. Most 
3D models provide a combination of a small number of cells 
with a large amount of scaffold (natural or synthetic), thereby 
optimizing cell–scaffold interactions; however, in most natural 
living tissues, cell–cell interactions are the most prominent.55 
Compared with conventional single-cell suspensions, MTs 
perfectly mimic native tissues in terms of structural and func-
tional properties.28 The differences in bone formation between 
the two seeding formats are striking. Both in vitro and in vivo, 
the advanced double 3D implants demonstrated more complete 
mineralization (Figure 4). Thus, a promising strategy to improve 
bone formation is to engineer bone in vitro by generating a 
functional bone implant from a combination of a biomaterial 
and cells, rather than to implant solely biomaterials.56
Conclusion
Nanostructured biomaterials for surgical implantations are 
designed as less invasive, resulting in earlier recovery and 
less risks for postoperative infection or complications. These 
innovations are expected to improve the quality of life of 
patients and expectancy, and reduce health care costs. The 
advanced double 3D bone implant developed here, combining 
a nanostructured bioactive biomaterial and predifferentiated 
osteogenic MTs, resulted in superior bone formation in vitro 
as well as in vivo. On the basis of this result, we suggest 
that it would be an improvement to reconsider the current 
tissue-engineering dogma by replacing single cells with 
MTs for seeding on scaffolds. In combination with further 
improvements in nanofibrous scaffolds design, we think 
that the double 3D strategy could lead to a new generation 
of improved engineered bone grafts, with faster production 
times and potentially reduced costs. This concept of tissue 
engineering is not limited to bone and might be applied, for 
instance, to cardiovascular or skin tissue engineering.
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